AstraZeneca plc (NASDAQ: AZN) shares are trading lower by 2% after Berlin’s state hospital halted the company’s COVID-19 vaccination of women under the age of 55 years old.
Last week, AstraZeneca issued a fresh update of its phase three trial data for the COVID-19 vaccine after a U.S. health agency earlier this week questioned the accuracy of the trial data.
The British drugmaker’s latest update claims the vaccine developed with Oxford University is 76% effective in protecting against symptomatic cases of the virus, from 79% efficacy the company had previously reported.
Roku Inc (NASDAQ: ROKU) shares are trading higher by 2% after Truist Securities upgraded the stock from Hold to Buy.
Roku is a leading streaming platform in the U.S. The company generates revenue from advertising, distribution fees, hardware sales, OS licensing, and subscription sales.
(C) 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.